Elinor Wilson

Dr. Elinor Wilson R.N.
President of Assisted Human Reproduction Canada
In office February 14, 2007 – September 30, 2012 (during the pleasure of the Governor General)
Preceded by	agency established

Elinor Wilson is the President of Assisted Human Reproduction Canada, appointed February 14, 2007 until September 30, 2012.

Education

Wilson has a Master of Health Sciences from McMaster University, and PhD in Administration Management from Walden University in Minneapolis, Minnesota.

Career

In December 2006, Wilson was appointed President of Assisted Human Reproduction Canada (AHRC). The Agency is a regulatory agency of the Government of Canada, established by an Act of Parliament. As President, she is responsible to provide strategic leadership; manage the day-to-day activities of the Agency; develop corporate strategies and performance measurements; promote excellence and networking; and provide sound and informed advice in a sensitive domain.

Prior to her appointment with AHRC Wilson served as Chief Executive Officer for the Canadian Public Health Association, responsible for managing an operating program and project budget in excess of $15 million, and for building relationships with stakeholders, members, partners and donors across the public, private and NGO sectors. Wilson has also held a number of increasingly responsible positions with the Heart and Stroke Foundation of Canada.

Her professional activates are numerous, including past-member of the Institute of Population and Public Health Advisory Board at the Canadian Institutes of Health Research, and the Canadian Population Health Initiative Board. She was formerly Vice President of the World Heart Federation, President on the InterAmerican Heart Federation, and member of the World Health Organization Expert Advisory Group on Global Cessation Policy. During the WHO deliberations on the Framework Convention on Tobacco Control (FCTC) she was the NGO representative on the Canadian Government delegation to the FCTC.